Authors: WANDT H FRANK M EHNINGER G SCHNEIDER C BRACK N DAOUD A FACKLERSCHWALBE I FISCHER J GACKLE R GEER T HARMS P LOFFLER B OHL S OTREMBA B RAAB M SCHONROCKNABULSI P STROBEL G WINTER R LINK H

Citation: H. Wandt et al., SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/, Blood, 91(10), 1998, pp. 3601-3606

Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N

Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35

Authors: HUBNER G LINK H SCHONROCKNABULSI P WANDT H GRAMATZKI M LOFFLER B FACKLERSCHWALBE I QUEISSER W BRACK N GEER T RAAB M OHL S SCHNEIDER B SCHNEIDER C FREUND M POLIWODA H EHNINGER G

Citation: G. Hubner et al., INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL, Medizinische Klinik, 91, 1996, pp. 26-32

Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N

Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654

Authors: LINK H EHNINGER G",SCHONROCKNABULSI,GRAMATZKI,"FRANKE A EINSELE H TISCHLER J BRACK N OTREMBA B LUTZ M GACKLE R OHL S HEIDEMANN E WILHELM M LOFFLER B WEISS J GEER T DIEHL S WANDT H

Citation: H. Link et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 2723-2723